iteriontherapeutics.com

Iterion Therapeutics


Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immun...
View Top Employees for Iterion Therapeutics
img Website iteriontherapeutics.com
img Industry Biotechnology
img Location Houston, Texas, United States
img Employees 8
img Founded 2014
img HQ 2450 West Holcombe Boulevard
img Funding 21,375,000 USD
img Website iteriontherapeutics.com
img Industry Biotechnology
img Location Houston, Texas, United States
img Employees 8
img Founded 2014
img LinkedIn linkedin.com/company/iterion-therapeutics
img HQ 2450 West Holcombe Boulevard
img Funding 21,375,000 USD

Top Iterion Therapeutics Employees